Boehringer
Lilly accused of anti-competitive practices
May 17, 2011Amylin, Boehringer, diabetes, exenatide, lilly, linagliptin
Amylin Pharmaceuticals is suing Eli Lilly and Company for alleged anticompetitive activity around Lilly’s January agreement with Boehringer Ingelheim to …
Boehringer bets on Pradaxa to fill portfolio gaps
April 6, 2011Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa
Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …
FDA approves Boehringer’s Pradaxa
October 20, 2010Sales and Marketing Boehringer, Pradaxa, atrial fibrilation
Boehringer Ingelheim’s Pradaxa has stolen a march over its rivals by being the first new oral anticoagulant to reach the …
Cutting-edge cancer treatments showcased at ESMO
October 18, 2010Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine
The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …
Digital Pharma: Pharma iPhone app update
October 15, 2010Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone
The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …
Boehringer pulls ‘Pink Viagra’
October 11, 2010Sales and Marketing Boehringer, Girosa
Boehringer Ingelheim has discontinued development of its hypoactive sexual desire disorder drug Girosa after the FDA refused to approve it. …
FDA committee backs Pradaxa
September 23, 2010Sales and Marketing Boehringer, Pradaxa, atrial fibrilation
An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …
Digital Pharma: Boehringer gets social with Facebook
September 14, 2010Medical Communications Boehringer, Digital Pharma blog, Facebook
Boehringer Ingelheim is looking for fans on Facebook and wants its employees to be thought of as “superheroes, only with …
Generic competition hits Boehringer sales
August 9, 2010Sales and Marketing 2010 financials, Boehringer, Q2
Boehringer Ingelheim’s sales fell 5% in the first half of 2010, depressed by generic competition and then further dragged down …
Boehringer cheered by diabetes data
June 28, 2010Research and Development Boehringer, DPP-4, diabetes, linagliptin
Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …
Digital Pharma: Playing healthcare games
June 23, 2010Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games
Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …
Boehringer denies Micardis cancer link
June 14, 2010Sales and Marketing ACE-inhibitors, ARB, Boehringer, Micardis, drug safety
Boehringer Ingelheim has given a robust rebuttal to a Lancet report implicating its hypertension drug Micardis (telmisartan) in scares about …
Ogilvy wins Pradaxa account
June 3, 2010Medical Communications Boehringer, Ogilvy, Pradaxa
Boehringer Ingelheim has awarded OgilvyHealthPR the global communications brief for its oral blood-thinner Pradaxa. The agency was appointed after a …
Boehringer selects lead candidate for Alzheimer’s
May 24, 2010Research and Development Ablynx, Boehringer
Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …
Digital Pharma: Boehringer readies ‘diabetes hub’
May 20, 2010Medical Communications Boehringer, digital pharma, disease awareness campaigns, patient information
Boehringer Ingelheim will shortly unveil a ‘digital diabetes hub’ that combines educational videos, research tools, educational games and information on …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
